UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041303
Receipt number R000046457
Scientific Title Safety and efficacy of lower limb Neuromuscular Electrical Stimulation in persons with acute spinal cord injury
Date of disclosure of the study information 2020/10/01
Last modified on 2024/01/13 22:23:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and efficacy of lower limb Neuromuscular Electrical Stimulation in persons with acute spinal cord injury

Acronym

Safety and efficacy of lower limb Neuromuscular Electrical Stimulation in persons with acute spinal cord injury

Scientific Title

Safety and efficacy of lower limb Neuromuscular Electrical Stimulation in persons with acute spinal cord injury

Scientific Title:Acronym

Safety and efficacy of lower limb Neuromuscular Electrical Stimulation in persons with acute spinal cord injury

Region

Japan


Condition

Condition

Patients with spinal cord injury

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the this study is the immediate effect of the Neuromuscular Electrical Stimulation in patients with acute spinal cord injury

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Amount of change in quadriceps muscle thickness

Key secondary outcomes

Amount of change in quadriceps muscle strength


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Standard Physical Therapy and Neuromuscular Electrical Stimulation (2 weeks, 5 days a week, 40 minutes a day, 50 Hz, 300 s, 15-40 mA)

Interventions/Control_2

Standard Physical Therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with AIS C and D incomplete cervical spinal cord injuries admitted within 1 day of injury

Key exclusion criteria

If you have a pelvic or femoral fracture, If complications affecting muscle strength are observed, If adverse events are observed along the way

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Yusuke
Middle name
Last name Morooka

Organization

Saitama Medical University Faculty of Health

Division name

Department of Physical Therapy

Zip code

350-0496

Address

Moroyama-cho Iruma-gun, Saitama 981 Kawakado

TEL

049-295-1001

Email

morooka@saitama-med.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Morooka

Organization

Saitama Medical University Faculty of Health

Division name

Department of Physical Therapy

Zip code

350-0496

Address

Moroyama-cho Iruma-gun, Saitama 981 Kawakado

TEL

049-295-1001

Homepage URL


Email

morooka@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University Faculty of Health

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical University Faculty of Health

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Saitama Medical Center

Address

Kawagoe, Saitama 1981 Kamoda

Tel

049-228-3902

Email

smcrinri@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 01 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000046457

Publication of results

Unpublished


Result

URL related to results and publications

http://jsnpt20.umin.jp/images/gene_abstractbook.pdf

Number of participants that the trial has enrolled

49

Results

The relative differences between the initial and final results were -25.7% and -26.0% for the higher and lower sides, respectively, in the control group and -14.2% and -15.1%, respectively, in the NMES group, with significantly fewer reductions in both sides in the NMES group. The initial and final changes for the higher and lower sides were 0.4 and 0.4, respectively, in the control group and 0.8 and 1.3, respectively, in the NMES group, showing significant improvement in the lower side in the NMES group.

Results date posted

2024 Year 01 Month 13 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Participant (control and NMES groups) were age (67.7, 64.9 years), Sex (20 male/5 female, 19 male/5 female), BMI (23.5,23.2), AIS (13 C/12 D, 13 C/11 D), and injury mechanism (11 fall on level surface/fall 6/traffic accident 2/Other 6, 12 falls on level surface/fall 2/traffic accident 6/Other 4).

Participant flow

The study participants comprised consecutively enrolled individuals aged <90 years with cervical SCI classified as AIS grades C and D who were admitted to an acute care hospital within 48 hours of injury between February 2021 and March 2022. A total of 104 individuals were eligible during the study period. Excluding 39 of them who met the exclusion criteria. Sixty-five individuals who met the inclusion criteria were stratified according to the AIS grade and were randomly assigned to the control group (n=33) or the NMES group (n=32). During the study, 6 individuals in the control group were discharged or transferred early, 1 underwent reoperation, and 1 had a sudden change in condition. In the NMES group, 6 individuals were discharged or transferred early, and 2 developed delirium, all of whom were not followed up. One participant was assigned to the NMES group but did not receive NMES due to pre-existing dermatitis. However, he was analyzed as the NMES group according to the modified ITT analysis.
The final analysis included 25 and 24 individuals in the control and NMES groups, respectively.

Adverse events

No adverse events related to NMES, such as skin rash, myalgia, or discomfort during the procedure, occurred in the NMES group.

Outcome measures

The primary endpoints were the thicknesses of the rectus femoris and vastus medialis muscles and the L3 value of the LEMS. L3 motor function was evaluated on a 6-point scale from 0 to 5 points; the side with the higher value was the higher side, and the side with the lower value was the lower side.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 10 Month 01 Day

Date of IRB

2021 Year 01 Month 07 Day

Anticipated trial start date

2021 Year 02 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 03 Month 31 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2020 Year 08 Month 04 Day

Last modified on

2024 Year 01 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046457


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name